Skip to main content
Have a personal or library account? Click to login
Acute Circulatory Collapse and Advanced Therapies in Patients with COVID-19 Infection Cover

Acute Circulatory Collapse and Advanced Therapies in Patients with COVID-19 Infection

Open Access
|Dec 2021

References

  1. Kang Y, Chen T, Mui D, et al. Cardiovascular manifestations and treatment considerations in COVID-19. Heart. 2020 Aug;106(15):11321141. doi: 10.1136/heartjnl-2020-317056
  2. Agdamag ACC, Edmiston JB, Charpentier V, et al. Update on COVID-19 Myocarditis. Medicina (Kaunas). 2020 Dec 9;56(12):678. doi: 10.3390/medicina56120678
  3. Tzotzos SJ, Fischer B, Fischer H, Zeitlinger M. Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey. Crit Care. 2020 Aug 21;24(1):516. doi: 10.1186/s13054-020-03240-7
  4. Medina-Enríquez MM, Lopez-León S, Carlos-Escalante JA, Aponte-Torres Z, Cuapio A, Wegman-Ostrosky T. ACE2: the molecular doorway to SARS-CoV-2. Cell Biosci. 2020 Dec 30;10(1):148. doi: 10.1186/s13578-020-00519-8
  5. Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003 Jun 4;289(21):28019. doi: 10.1001/jama.289.21.JOC30885
  6. Clerkin KJ, Fried JA, Raikhelkar J, et al. COVID-19 and Cardiovascular Disease. Circulation. 2020 May 19;141(20):16481655. doi: 10.1161/CIRCULATIONAHA.120.046941
  7. Shah JZ, Kumar SA, Patel AA. Myocarditis and Pericarditis in Patients with COVID-19. Heart Views. Jul–Sep 2020;21(3):209214. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_154_20
  8. Ortuno S, Jozwiak M, Mira JP, Nguyen LS. Case Report: Takotsubo Syndrome Associated With Novel Coronavirus Disease 2019. Front Cardiovasc Med. 2021 Feb 22;8:614562. doi: 10.3389/fcvm.2021.614562
  9. Sala S, Peretto G, Gramegna M, et al. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. Eur Heart J. 2020 May 14;41(19):18611862. doi: 10.1093/eurheartj/ehaa286
  10. Ranard LS, Fried JA, Abdalla M, et al. Approach to Acute Cardiovascular Complications in COVID-19 Infection. Circ Heart Fail. 2020 Jul;13(7):e007220. doi: 10.1161/CIRCHEARTFAILURE.120.007220
  11. Greene AG, Saleh M, Roseman E, Sinert R. Toxic shock-like syndrome and COVID-19: Multisystem inflammatory syndrome in children (MIS-C). Am J Emerg Med. 2020 Nov;38(11):2492.e52492.e6. doi: 10.1016/j.ajem.2020.05.117
  12. Clerkin KJ, Fried JA, Raikhelkar J, et al. COVID-19 and Cardiovascular Disease. Circulation. 2020 May 19;141(20):16481655. doi: 10.1161/CIRCULATIONAHA.120.046941
  13. Al Abbasi B, Torres P, Ramos-Tuarez F, et al. Cardiac Troponin-I and COVID-19: A Prognostic Tool for In-Hospital Mortality. Cardiol Res. 2020 Dec;11(6):398404. doi: 10.14740/cr1159
  14. Guo T, Fan Y, Chen M, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 Jul 1;5(7):811818. doi: 10.1001/jamacardio.2020.1017
  15. Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020 May 12;323(18):17751776. doi: 10.1001/jama.2020.4683
  16. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):12391242. doi: 10.1001/jama.2020.2648
  17. Chow J, Alhussaini A, Calvillo-Argüelles O, Billia F, Luk A. Cardiovascular Collapse in COVID-19 Infection: The Role of Venoarterial Extracorporeal Membrane Oxygenation (VA-ECMO). CJC Open. 2020 Apr 8;2(4):273277. doi: 10.1016/j.cjco.2020.04.003
  18. Sánchez-Recalde Á, Solano-López J, Miguelena-Hycka J, Martín-Pinacho JJ, Sanmartín M, Zamorano JL. COVID-19 and cardiogenic shock. Different cardiovascular presentations with high mortality. Rev Esp Cardiol (Engl Ed). 2020 Aug;73(8):669672. doi: 10.1016/j.rec.2020.04.012
  19. Hollenberg SM, Safi L, Parrillo JE, et al. Hemodynamic Profiles of Shock in Patients With COVID-19. Am J Cardiol. 2021 Aug 15;153:135139. doi: 10.1016/j.amjcard.2021.05.029
  20. Makdisi G, Wang IW. Extra Corporeal Membrane Oxygenation (ECMO) review of a lifesaving technology. J Thorac Dis. 2015 Jul;7(7):E16676. doi: 10.3978/j.issn.2072-1439.2015.07.17
  21. Pavlushkov E, Berman M, Valchanov K. Cannulation techniques for extracorporeal life support. Ann Transl Med. 2017 Feb;5(4):70. doi: 10.21037/atm.2016.11.47
  22. Napp LC, Bauersachs J. Triple cannulation ECMO. InTech, 2016 Sep 14;7999. doi: 10.5772/63392
  23. Olson SR, Murphree CR, Zonies D, et al. Thrombosis and Bleeding in Extracorporeal Membrane Oxygenation (ECMO) Without Anticoagulation: A Systematic Review. ASAIO J. 2021 Mar 1;67(3):290296. doi: 10.1097/MAT.0000000000001230
  24. Ratnani I, Tuazon D, Zainab A, Uddin F. The Role and Impact of Extracorporeal Membrane Oxygenation in Critical Care. Methodist DeBakey Cardiovasc J. Apr–Jun 2018;14(2):110119. doi: 10.14797/mdcj-14-2-110
  25. Tabatabai A, Galvagno, SM Jr, O’Connor JV, Scalea TM, Deatrick KB. Extracorporeal Life Support (ECLS): A Review and Focus on Considerations for COVID-19. Shock. 2021 Jun 1;55(6):742751. doi: 10.1097/SHK.0000000000001677
  26. Badulak J, Antonini MV, Stead CM, et al. ELSO COVID-19 Working Group Members. Extracorporeal Membrane Oxygenation for COVID-19: Updated 2021 Guidelines from the Extracorporeal Life Support Organization. ASAIO J. 2021 May 1;67(5):485495. doi: 10.1097/MAT.0000000000001422
  27. Barbaro RP, MacLaren G, Boonstra PS, et al. Extracorporeal Life Support Organization. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry. Lancet. 2020 Oct 10;396(10257):10711078. doi: 10.1016/S0140-6736(20)32008-0
  28. Aissaoui N, El-Banayosy A, Combes A. How to wean a patient from veno-arterial extracorporeal membrane oxygenation. Intensive Care Med. 2015 May;41(5):9025. doi: 10.1007/s00134-015-3663-y
  29. Henry B, Thiagarajan R, Cooper D. Outcomes of repeated extracorporeal membrane oxygenation in adults: Analysis of the ELSO Registry. Crit Care Med. 2020 Jan;48(1):4. doi: 10.1097/01.ccm.0000618528.27416.ce
  30. Posluszny J, Rycus PT, Bartlett RH, et al. ELSO Member Centers. Outcome of Adult Respiratory Failure Patients Receiving Prolonged (≥14 Days) ECMO. Ann Surg. 2016 Mar;263(3):57381. doi: 10.1097/SLA.0000000000001176
  31. Wong A, Sin S. (2020). Short-term mechanical circulatory support (intra-aortic balloon pump, Impella, extracorporeal membrane oxygenation, TandemHeart): a review. Ann Transl Med. 2020 Jul;8(13):829. doi: 10.21037/atm-20-2171
  32. Jiritano F, Lo Coco V, Matteucci M, Fina, D, Willers A, Lorusso R. Temporary Mechanical Circulatory Support in Acute Heart Failure. Card Fail Rev. 2020 Mar 16;6:e01. doi: 10.15420/cfr.2019.02
  33. Pappalardo F, Scandroglio AM, Latib A. Full percutaneous biventricular support with two Impella pumps: the Bi-Pella approach. ESC Heart Fail. 2018 Jun;5(3):368371. doi: 10.1002/ehf2.12274
  34. Thiele H, Zeymer U, Neumann FJ, et al. IABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012 Oct 4;367(14):128796. doi: 10.1056/NEJMoa1208410
  35. Seyfarth M, Sibbing D, Bauer I, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008 Nov 4;52(19):15848. doi: 10.1016/j.jacc.2008.05.065
  36. Ouweneel DM, Eriksen E, Sjauw KD, et al. Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction. J Am Coll Cardiol. 2017 Jan 24;69(3):278287. doi: 10.1016/j.jacc.2016.10.022
  37. Nakamura M, Imamura T. Practical Management of ECPELLA. Int Heart J. 2020 Nov 28;61(6):10941096. doi: 10.1536/ihj.20-172
  38. Yastrebov K, Brunel L, Paterson HS, et al. Implantation of Impella CP left ventricular assist device under the guidance of three-dimensional intracardiac echocardiography. Sci Rep. 2020 Oct 15;10(1):17485. doi: 10.1038/s41598-020-74220-8
  39. Ammirati E, Veronese G, Brambatti M, et al. Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction. J Am Coll Cardiol. 2019 Jul 23;74(3):299311. doi: 10.1016/j.jacc.2019.04.063
  40. Ryu DR, Heo JW, Lee SH, et al. Fulminant myocarditis: the role of cardiac magnetic resonance imaging. Int J Cardiol. 2013 Sep 30;168(2):e589. doi: 10.1016/j.ijcard.2013.07.002
  41. Marcinkiewicz K, Petryka-Mazurkiewicz J, Nowicki M, et al. Acute heart failure in the course of fulminant myocarditis requiring mechanical circulatory support in a healthy young patient after coronavirus disease 2019. Kardiol Pol. 2021;79(5):583584. doi: 10.33963/KP.15888
  42. Ruiz JG, Kandah F, Dhruva P, Ganji M, Goswami R. Case of Coronavirus Disease 2019 Myocarditis Managed With Biventricular Impella Support. Cureus. 2021 Feb 7;13(2):e13197. doi: 10.7759/cureus.13197
  43. Salamanca J, Díez-Villanueva P, Martínez P, et al. COVID-19 “Fulminant Myocarditis” Successfully Treated With Temporary Mechanical Circulatory Support. JACC Cardiovasc Imaging. 2020 Nov;13(11):24572459. doi: 10.1016/j.jcmg.2020.05.003
  44. Chitturi KR, Thacker S, Al-Saadi MA, Kassi M. Successful treatment of acute heart failure in COVID-19-induced cytokine storm with tocilizumab: a case report. Eur Heart J Case Rep. 2020 Jul 17;4(FI1):16. doi: 10.1093/ehjcr/ytaa188
  45. NIH.gov [Internet]. Bethesda, MD: National Institutes of Health; c2021. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines; 2021 Oct 27 [cited 2021 Oct 31]. Available from: https://www.covid19treatmentguidelines.nih.gov/
  46. Goligher EC, Bradbury CA, McVerry BJ, et al. REMAP-CAP Investigators; ACTIV-4a Investigators; ATTACC Investigators. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26;385(9):777789. doi: 10.1056/NEJMoa2103417
DOI: https://doi.org/10.14797/mdcvj.1048 | Journal eISSN: 1947-6108
Language: English
Page range: 43 - 52
Submitted on: Oct 7, 2021
Accepted on: Oct 18, 2021
Published on: Dec 15, 2021
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services

© 2021 Rishi Thaker, Aayush Shah, Ju Kim, Mahwash Kassi, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.